Clinical Trial Results:
A 22-week randomized, multicenter, parallel-group, double-blind study to compare a pimecrolimus 1 % (Elidel) twice daily (b.i.d.) maintenance dosing regimen to a once daily (o.d.) maintenance dosing regimen in the management of atopic dermatitis in pediatric subjects.
Summary
|
|
EudraCT number |
2004-000940-26 |
Trial protocol |
FI AT GB |
Global completion date |
05 Sep 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
19 May 2018
|
First version publication date |
19 May 2018
|
Other versions |
|
Summary report(s) |
CASM981C2314 NVS CTR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.